文献速递慢性静脉疾病

氰基丙烯酸酯消融与射频消融治疗下肢静脉功能不全的对比分析

Comparative analysis of the results of cyanoacrylate ablation and radiofrequency ablation in the treatment of venous insufficiency.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2021-09-16

本研究回顾性比较了氰基丙烯酸酯消融(CAA)与射频消融(RFA)治疗大隐静脉(GSV)功能不全的效果,RFA组634例、CAA组246例。两组术后5年闭合率、症状改善及CEAP分级、超声表现相似,CAA因非热、无需肿胀麻醉且适用多数患者,结果与RFA相当。

要点

  • CAA与RFA术后5年闭合率、症状缓解及CEAP改善相似。
  • CAA为非热消融且无需肿胀麻醉,适用多数GSV功能不全患者。
  • 长期疗效与成本分析仍需更大样本研究证实。

核心结论

  • CAA似乎是GSV功能不全的理想治疗方式,因其适用于多数患者、非热且无需肿胀麻醉,结果与RFA相当。
  • 长期结局与成本分析需更大样本研究确认。

研究设计与样本

  • 回顾性对比研究,纳入5年期间因GSV功能不全接受RFA(634例)或CAA(246例)的患者。
  • 比较术前与术后CEAP分级、症状、复发及多普勒超声表现。

主要发现

  • 两组全部静脉在术后第5天闭合。
  • 术后1个月闭合率RFA为97.3%、CAA为98.7%。
  • 术后5年总体闭合率RFA为93.1%、CAA为91.1%。
  • 术后5年无症状生存率RFA为73.5%、CAA为72.0%。
  • 静脉临床严重程度评分RFA由5.9±1.2降至0.9±0.8,CAA由5.8±0.9降至0.8±0.6。

关键数值与推荐

  • Aberdeen静脉问卷评分RFA由19.7±5.5降至4.8±1.5,CAA由18.9±5.8降至4.9±1.4。
  • 两组术后症状、CEAP分级及多普勒超声表现相似。

临床怎么用

  • 对GSV功能不全可考虑CAA作为非热、免肿胀麻醉的消融选择,短期与中期闭合及症状改善与RFA相当。
  • 决策时仍需结合长期随访与成本因素个体化选择。

局限性

  • 原文未报告研究设计的具体类型(如是否回顾性)与随访完整率。
  • 长期结局与成本分析需更大样本研究确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Varicose vein treatment has shifted to less invasive techniques owing to the complications associated with traditional treatment. The present study was designed to compare the effectiveness of cyanoacrylate ablation (CAA) with radiofrequency ablation (RFA). METHODS: Patients who had undergone RFA vs CAA (634 vs 246 patients) to treat great saphenous vein (GSV) insufficiency during a 5-year period were included in the present study. The preoperative and postoperative CEAP (clinical, etiologic, anatomic, pathophysiologic) class, symptoms, recurrence, and Doppler ultrasound findings were compared. RESULTS: All the veins in both groups were occluded at day 5. The 1-month closure rates were 97.3% and 98.7% for RFA and CAA, respectively. The overall postoperative closure rates at 5 years were 93.1% and 91.1% for RFA and CAA, respectively. The postoperative symptoms, CEAP class, and Doppler ultrasound findings were similar in both groups. The 5-year symptom-free survival rates were 73.5% and 72.0% in the RFA and CAA groups, respectively. The venous clinical severity scores had decreased from 5.9 ± 1.2 to 0.9 ± 0.8 and 5.8 ± 0.9 to 0.8 ± 0.6 in the RFA and CAA groups, respectively. The Aberdeen varicose vein questionnaire scores had decreased from 19.7 ± 5.5 to 4.8 ± 1.5 in the RFA group and from 18.9 ± 5.8 to 4.9 ± 1.4 in the CAA group. CONCLUSIONS: CAA seems to be the ideal treatment for GSV insufficiency because it is suitable for most patients and is nonthermal and nontumescent, with satisfactory results comparable to those with RFA. Long-term outcomes and cost analyses from larger series are required to confirm our findings.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Daylan A, İslamoğlu F. Comparative analysis of the results of cyanoacrylate ablation and radiofrequency ablation in the treatment of venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34536569. doi:10.1016/j.jvsv.2021.09.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。